On Nov. 12, 2024, researchers from the University of Basel and University Hospital Basel announced they had developed…
On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…
On Nov. 5, 2024, Scripps research scientists reported they have shown that Alzheimer’s and alcohol use disorder (AUD)…
On Nov. 3, 2024, the world’s largest biodiversity summit, known as COP16, concluded with several landmark decisions, including…
On Nov. 1, 2024, researchers reported results from a study that show a low-sugar diet during pregnancy and…
On Oct. 31, 2024, researchers from the University of Pittsburgh reported results of a study that showed drug-related…
On Oct. 30, 2024, an international research team led by the University of Bonn reported results of a…
On Oct. 28, 2024, the Johns Hopkins University and Johns Hopkins Medicine, together with descendants of Henrietta Lacks,…
On Oct. 23, 2024, Pfizer announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee…
On Oct. 23, 2024, the University of Rochester announced that the Saunders Foundation, led by University Trustee Emeritus…
On Oct. 21, 2024, in one of the largest-ever studies of DNA and brain volume, researchers announced they…
On Oct. 21, 2024, Rice University’s Baker Institute for Public Policy reported that hospital service prices surged more…
On Oct. 18, 2024, a study published in JAMA Ophthalmology, found that approximately 4.22 million people in the…
On Oct. 18, 2024, a research team led by Radboud university medical center reported that a new PET…
On Oct. 16, 2024, researchers from the Wellcome Sanger Institute, Newcastle University and their collaborators announced they had…
On Oct. 16, 2024, Sanofi announced it will contribute $18 million to three Historically Black Medical Schools to…
On Oct. 14, 2024, Lundbeck and Longboard Pharmaceuticals announced an agreement for Lundbeck to acquire Longboard for payment…
On Oct. 11, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved HYMPAVZI™ (marstacimab-hncq)…
On Oct. 10, 2024, Genentech announced today that the U.S. Food and Drug Administration (FDA) approved ItovebiTM (inavolisib),…
On Oct. 7, 2024, Columbia University researchers announced they had developed a new optical pooled screening approach called…
On Oct. 4, 2024, Exact Sciences announced the U.S. Food and Drug Administration (FDA) had approved the Cologuard…
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…
On Oct. 2, 2024, Eli Lilly and Company announced a $4.5 billion investment to create the Lilly Medicine…
On Sept. 30, 2024, Amneal Pharmaceuticals announced that it had launched CREXONT ® (carbidopa and levodopa) extended-release capsules…
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
On Sept. 26, 2024, a team of scientists in Peking University in Beijing, China announced that a 25-year-old…
On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…
On Sept. 16, 2024, researchers from NHS Blood and Transplant (Bristol), NHSBT’s International Blood Group Reference Laboratory (IBGRL)…
On Sep. 13, 2024, a Cleveland Clinic study was announced that identified key factors that can impact the…
On Sept. 13, 2024, researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the…